The Therapy remains reasonably new in terms of widespread acceptance, and It truly is generally labeled as an "off-label" use for depression, this means its use On this context hasn't been formally authorised from the FDA. This classification causes it to be hard for Medicare to justify coverage. Me and https://g.co/kgs/7Pv1MXH